Yusuke Iemura, Makito Miyake, Shinji Fukui, Tomomi Fujii, Sayuri Ohnishi, Shunta Hori, Yosuke Morizawa, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto. Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancer.Current urology. 2023, 17 (4): 229-235
Rabea Ahmed Gadelkareem, Ahmed Mahmoud Abdelraouf, Abdelfattah Ibrahim Ahmed, Ahmed Mohammed El-Taher, Hosny Mahmoud Behnsawy. Predictors of time-to-nadir serum creatinine after drainage of bilaterally obstructed kidneys due to bladder cancer.Current urology. 2023, 17 (4): 246-250
Luca Di Gianfrancesco. The association between postvoid residual and response to standard therapy in male and female patients with non-muscle-invasive bladder cancer.Current urology. 2023, 17 (4): 251-256
Tarun Jindal, Ankush Sarwal, Prateek Jain, Rajan Koju, Satyadip Mukherjee. A retrospective analysis of the factors associated with increased risk of readmission within 30 days after primary transurethral resection of bladder tumor.Current urology. 2023, 17 (4): 257-261
Seyed Behzad Jazayeri, Hojat Dehghanbanadaki, Mahdie Hosseini, Pourya Taghipour, Michael W Bacchus, Elizabeth A Di Valerio, Elnaz Sarabchian, K C Balaji, Mark Bandyk. Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy.Current urology. 2023, 17 (4): 262-267
Mai Hori, Kazuki Maki, Yumiko Okuno, Koji Mikami, Takumi Takeuchi. A radiation-related second primary gastrointestinal stromal tumor in the bladder.Current urology. 2023, 17 (4): 268-270
Maria A Bantounou, Josip Plascevic, Lewis MacDonald, Man Chun Wong, Neasa O'Connell, Helen F Galley. Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review.Current urology. 2023, 17 (4): 271-279
Daniel Da Silva Ferreira, Amit Satish Bhattu, Ahmed Adam. Miniaturizing the approach to upper tract renal calculi: Is smaller always better? A narrative review.Current urology. 2023, 17 (4): 280-285
Sumesh Padayachee, Ahmed Adam, June Fabian. The impact of diabetes and hypertension on renal allograft survival- A single center study.Current urology. 2023, 17 (4): 286-291
Benedikt Hoeh, Marina Kosiba, Mike Wenzel, Nicola Meister, Felix Preisser, Shahrokh F Shariat, Jan Lukas Hohenhorst, Andreas Becker, Philipp Mandel, Severine Banek, Frederik Roos, Pierre I Karakiewicz, Felix K H Chun, Luis A Kluth. Comparison of survival outcomes between laparoscopic versus open radical nephroureterectomy in upper tract urothelial cancer patients: Experiences of a tertiary care single center.Current urology. 2023, 17 (4): 292-298
Alexandr M Pinkhasov, Matthew Beamer, Daniel Shulman, Rachel Yakubov, Esther Pinkhasov, Sergey Kravchick. A novel technique for unilateral dissection of the penile neurovascular bundle to prevent loss of penile sensation during treatment of Peyronie's disease-Initial results of a pilot study.Current urology. 2023, 17 (4): 299-302
Matteo Massanova, Rebecca Vere, Sophie Robertson, Felice Crocetto, Biagio Barone, Lorenzo Dutto, Imran Ahmad, Mark Underwood, Jonathan Salmond, Amit Patel, Giuseppe Celentano, Jaimin R Bhatt. Clinical and prostate multiparametric magnetic resonance imaging findings as predictors of general and clinically significant prostate cancer risk: A retrospective single-center study.Current urology. 2023, 17 (3): 147-152
Paolo Tralongo, Sebastiano Bordonaro, Giuseppe Di Lorenzo, Ugo De Giorgi, Nicolò Borsellino, Gaetano Facchini, Sabrina Rossetti, Giuseppe Fornarini, Vito Longo, Antonino Carmelo Tralongo, Francesca Caspani, Massimiliano Spada, Nicola Calvani, Paolo Carlini. Feasibility of cabazitaxel in octogenarian prostate cancer patients.Current urology. 2023, 17 (3): 153-158